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A B S T R A C T
Closed-loop neuromodulation is presumed to be the logical evolution for improving the effectiveness of deep
brain stimulation (DBS) treatment protocols (Widge et al., 2018). Identifying symptom-relevant biomarkers that
provide meaningful feedback to stimulator devices is an important initial step in this direction. This report
demonstrates a technique for assaying neural circuitry hypothesized to contribute to OCD and DBS treatment
outcomes. We computed phase-lag connectivity between LFPs and EEGs in thirteen treatment-refractory OCD
patients. Simultaneous recordings from scalp EEG and externalized DBS electrodes in the ventral capsule/ventral
striatum (VC/VS) were collected at rest during the perioperative treatment stage. Connectivity strength between
midfrontal EEG sensors and VC/VS electrodes correlated with baseline OCD symptoms and 12-month post-
treatment OCD symptoms. Results are qualified by a relatively small sample size, and limitations regarding the
conclusiveness of VS and mPFC as neural generators given some concerns about volume conduction. Nonetheless,
findings are consistent with treatment-relevant tractography findings and theories that link frontostriatal
hyperconnectivity to the etiopathogenesis of OCD. Findings support the continued investigation of connectivity-
based assays for aiding in determination of optimal stimulation location, and are an initial step towards the
identification of biomarkers that can guide closed-loop neuromodulation systems.
Deep brain stimulation (DBS) holds promise as a novel treatment for
severe and treatment-refractory neuropsychiatric disorders. DBS in the
ventral capsule/ventral striatum (VC/VS) is especially helpful for some
patients with Obsessive-Compulsive Disorder (OCD). Not all patients
receive therapeutic benefit from DBS, and identifying OCD-relevant
pathophysiology may improve therapy effectiveness and existing DBS
protocols.
OCD is frequently linked to aberrant structure and function within a
frontostriatal network that includes the medial prefrontal cortex (mPFC)
and VS. OCD patients enrolled in DBS trials demonstrate
hyperconnectivity between the mPFC and VS, which seems to be
modulated by VC/VS-DBS treatment (Figee et al., 2013). Connectivity
within frontostriatal networks—including the mPFC-VS circuit—is
facilitated by delta (i.e., 1–4 Hz) oscillations (Wu et al., 2018), which are
more pronounced at rest in OCD patients (Kamaradova et al., 2018;
Perera et al., 2019; Koprivova et al., 2013). In general, successful treat-
ment with VC/VS-DBS appears to depend on modification of this
mPFC-VS delta-band networking. However, the precise mechanisms by
which delta oscillations (re)code for symptom change are unclear. Delta
amplitude (1–4 Hz) is suppressed by active VC/VS-DBS during
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symptom-provocation in treatment responders (Figee et al., 2013), but is
similar across OFF/ON states in treatment responders at rest (Smith et al.,
2020; Smolders et al., 2013). On the other hand, individual differences in
modulation of resting delta from OFF to ON states predicts fewer post-
treatment symptoms and more symptom improvement (Smith et al.,
2020). Treatment-relevant neural changes are hypothesized to rely on
DBS stimulation of fibers passing through the internal capsule
dorsal-posterior to the VS and Nucleus accumbens (NAc). For example,
treatment response may depend on the extent to which DBS perturbs
fiber paths that support oscillatory coupling between the mPFC and VS.
Fig. 1. Connectivity between the ventral capsule (VC) and
medial prefrontal cortex (mPFC) is important to OCD
symptomatology and may be normalized by VC/VS-DBS.
Data in this figure reflect resting-state connectivity
before stimulation. (a) Location of DBS electrodes for 12 of
13 participants (one participant was missing postoperative
imaging), overview of study design, and study hypotheses.
DBS is hypothesized to reduce mPFC-VC connectivity. A
bipolar-referenced Fz-FCz electrode was used as an indi-
cator of mPFC function. (b) Spatial distribution of con-
nectivity strength for each DBS electrode. The shaded
green area indicates the Nucleus accumbens (NAc), which
was the stereotaxic target for electrode implantation. Dots
indicate positions of DBS electrodes. Each dot is one DBS
electrode for one participant. Dot color indicates intensity
of connectivity strength with warmer colors (i.e., yellow)
indicating stronger connectivity.
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This may be especially the case for right-lateralized fibers (Figee et al.,
2013; Baldermann et al., 2019; Valencia-Alfonso et al., 2012). Insofar as
VC/VS-DBS works by disrupting mPFC-VS hyperconnectivity (Suetens
et al., 2014; Mavridis, 2019; Gibson et al., 2017), it may be the case that
electrodes in the VC showing stronger connectivity with mPFC at base-
line are more likely to disrupt mPFC-VS hyperconnectivity and facilitate
improvement of symptoms. In this way, measurement of perioperative
mPFC-VS connectivity may facilitate postoperative selection of stimula-
tion contacts with a high likelihood of desirable clinical effects. Before
the realization of this possibility, it will be important to demonstrate the
clinical significance of specific brain regions and oscillatory frequencies.
Thus, we evaluated the correspondence between mPFC-VS perioperative
connectivity, treatment outcomes, and DBS electrode location to 1) test
hypotheses (Fig. 1a) regarding the importance of rightward mPFC-VS
connectivity for treatment response to DBS, and 2) demonstrate a
novel technique with possible clinical utility in guiding selection of DBS
stimulation contacts postoperatively.
This study included thirteen patients (seven females) undergoing
surgery for implantation of DBS leads (Model 3387 or 3389 DBS Lead;
Medtronic; Minneapolis, MN, USA) bilaterally into the ventral internal
capsule with at least one contact within the VS or NAc (Fig. 1b). Patient
demographics and adverse events are shown in Supplementary Table 1.
Additional details regarding study procedures and clinical outcomes are
reported in Huys et al. (2019) The primary outcome variable was change
in OCD symptoms (Yale-Brown Obsessive Compulsive Scale, YBOCS)
from baseline to twelve month follow up; baseline YBOCS and twelve
month YBOCS scores (e.g., not change scores) were secondary outcome
variables (Huys et al., 2019). Most patients were responders at twelve
month follow up (11/13; 35% reduction in YBOCS scores).
Simultaneous (5000 Hz sampling rate) scalp EEGs and intracranial
LFPs (externalized DBS electrodes) were recorded 1–2 days after DBS
surgery (i.e., perioperative, before stimulation was turned on). Resting-
state recordings were approximately 8 min long with alternating eyes
open or eyes closed blocks. There were six 1-min eyes-closed segments,
and five eyes-open segments lasting 26-s each. A combination of zero-
phase FIR filtering (1–40 Hz bandpass), thresholding (150 μV), and
ICA component subtraction was used to correct for nonneurogenic arti-
facts in line with recent recommendations (Lio et al., 2018). EEGs and
LFPs were bipolar referenced (Fz-FCz scalp sensor; six bipolar DBS sen-
sors, left: 0–1, 1–2, 2–3; right: 8–9, 9–10, 10–11 with 0–1 and 8–9 being
the most ventral). Debiased Weighted Phase-Lag Index [dwPLI; Vinck
et al., 2011] was used for estimating phase-synchronization between
VC/VS and mPFC in the delta frequency band (1–4 Hz). This
phase-synchronization index was our measure of functional connectivity.
DBS electrodes were localized using Lead-DBS software (http
://www.lead-dbs.org) following the procedure described in (Horn and
Kuhn, 2015) with some modifications. Briefly, postoperative computer
tomography scans were linearly co-registered to preoperative MRI using
Advanced Normalization Tools and the Lead-DBS brain shift correction
module. Images were then normalized into International Consortium for
Brain Mapping 2009b nonlinear asymmetric space using the SyN
approach. Results were visually reviewed to confirm accuracy. Each bi-
polar sensor was mapped to the Euclidean midpoint between the co-
ordinates representing the two electrode contacts from which the signal
was recorded.
Connectivity was examined between VC/VS-DBS electrodes and the
Fz-FCz scalp sensor. Several contacts were identified as therapeutic for
each patient, nonetheless, the therapeutic contact (according to patient’s
subjective wellbeing) for the right-hemisphere at 12-month follow up
was either 9–10 or 10–11 (dorsal and middle contacts) in 8/13 cases
(Supplementary Table 2). Right-dorsal therapeutic contacts are consis-
tent with previous work showing that this region is important for VC/VS-
DBS treatment response (Baldermann et al., 2019; Li et al., 2020), and
thus we focused our analyses on these right-dorsal electrodes. For each
participant, the middle or dorsal DBS electrodes (9–10 or 10–11) with the
strongest connectivity to Fz-FCz were used for correlation with outcome
variables. One participant did not have useable data for either the 9–10
or 10–11 electrode, so the 8–9 electrode was used. Spearman rank order
correlations are reported. To balance for type 1 and type 2 statistical
errors, an uncorrected p < .05 was considered significant, but p-values
corrected using the False-Discovery Rate method (FDR (Benjamini and
Hochberg, 1995);) are also reported for comparison.
Connectivity coefficients between VC electrodes and FCz-Fz are dis-
played in Fig. 1b. Dorsal intracranial contacts (2–3, 10–11) demonstrated
numerically stronger connectivity with FCz-Fz than ventral contacts
(0–1, 8–9), but the difference in connectivity strength between dorsal
and ventral contacts was not statistically significant (Wilcoxon signed
rank test uncorrected ps > .7).
Fig. 2 shows the spatial distribution of connectivity-symptom corre-
lations across six DBS contacts (left: 0–1, 1–2, 2–3; right: 8–9, 9–10,
10–11). The position of DBS contacts varied for each participant, and the
same six correlation coefficients (at 0–1, 1–2, 2–3, 8–9, 9–10, 10–11) are
depicted at each individual’s DBS contact. In general, contacts that were
in right-dorsal regions of VC were more strongly related to OCD
symptoms.
Right lateralized frontostriatal connectivity was not significantly
related to symptom change (r¼ 0.239, p¼ .431, FDR-p¼ .431) using the
contact that was most strongly coupled with FCz-Fz. Instead, intracranial
contacts that were most strongly coupled with FCz-FZ correlated with
total OCD symptoms at baseline (r ¼ 0.646, p ¼ .017, FDR-p ¼ .052;
Fig. 2a) and after one year (r ¼ 0.583, p ¼ .036, FDR-p ¼ .054; Fig. 2b),
such that stronger connectivity predicted more OCD symptoms. There
was a nonsignificant trend for stronger connectivity between FCz-Fz and
10–11 to predict greater reduction in symptoms at twelve month follow
up (r ¼ 0.519, p ¼ .102, FDR-p ¼ .392; Fig. 2c).
We hypothesized that perioperative mPFC-VS delta connectivity
measured near the site of electrical stimulation would be related to
symptom change and fewer posttreatment symptoms, especially for the
right hemisphere. Connectivity strength was related to total symptoms at
baseline and at follow-up, but the relationship between connectivity
strength and symptom change was not statistically significant.
Connectivity-symptom correlations were present for both right hemi-
sphere and left hemisphere VC/VS electrodes, with somewhat different
spatial distributions. Connectivity-symptom correlations were largest at
right-dorsal VC regions (Fig. 2) consistent with previous tractrographic
findings (Baldermann et al., 2019; Li et al., 2020).
Recent tractographic findings examining mechanisms of VC/VS-DBS
treatment have pointed towards pathways near dorsal DBS contacts
(Baldermann et al., 2019; Li et al., 2020; Liebrand et al., 2019). The
present results are generally congruent with this previous work, and
non-significant findings (e.g., Fig. 2c) could be the result of low statistical
power, change-score reliability, and limitations of our LFP and EEG
recording apparatus. For example, the recording volume of a
bipolar-referenced electrode spaced apart 0.5 or 1.5 mm may have dif-
ficulty assessing pathways important for treatment outcome that lay
dorsal to recording contacts. LFPs may also be diluted by activity in
nearby grey matter (e.g., NAc; Fig. 1b). In this way, LFP recordings may
be a crude representation of VC white matter function. Similarly, volume
conduction in EEG recordings from frontal areas other than the mPFC
(e.g., supplementary motor area) probably contributed to connectivity
estimates and limits conclusions regarding the roles of the VC and mPFC
specifically. Moreover, the VC and mPFC are two of many brain regions
believed to play a role in the pathophysiology of OCD, and it is a rela-
tively open question whether regions outside a VC-mPFC circuit are
more/less informative with regard to prediction of change in
self-reported symptoms (Baldermann et al., 2019; Li et al., 2020; Milad
and Rauch, 2012; Fridgeirsson et al., 2020). The small sample used in this
report precludes generalization of findings to the population, and repli-
cation of the present results will be important before drawing firm con-
clusions about translational potential or clinical utility. Notwithstanding
these limitations, the results are consistent with the hypothesis that
frontostriatal networking in the delta frequency is relevant to OCD
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etiopathogenesis (Figee et al., 2011, 2013; Milad and Rauch, 2012) and
support the notion that online monitoring of disease-relevant systems
may be helpful for optimizing the efficacy of DBS treatments (Widge
et al., 2018; Widge and Miller, 2019).
With regard to the study limitations noted above, future work will
strive to collect recordings from mPFC and VS with high spatial resolu-
tion to clarify the importance of specific frontostriatal regions. In addi-
tion, simultaneous recordings collected from regions outside the mPFC
and VS is another important goal, as multisite-multimodal recordings
may be particularly informative for characterizing systemic changes
resulting from DBS. For example, with some modification to surgical
procedures, recordings during surgery from multiple loci across central
(e.g., mPFC, VS, dlPFC, parietal cortex) and autonomic (e.g., vagal tone,
skin conductance, pupillary response, cortisol) nervous systems could be
used to fine tune placement of DBS electrodes (Bijanki et al., 2019; Ooms
et al., 2014; Riva-Posse et al., 2019). Moreover, readouts from multisite
implants (e.g., permanent intracranial electrodes in both the mPFC and
VS) may be useful for adaptively optimizing DBS parameters (e.g.,
timing, frequency, stimulation location) in real-time (Zelmann et al.,
2020). To this end, there are some promising initial findings suggesting
that specific cognitive (Basu et al., 2020) and emotional (Bijanki et al.,
2019; Riva-Posse et al., 2019) states can be induced with a combination
of multisite recordings and adaptive/closed-loop DBS. With continued
investigation and refinement of techniques, there is hope that these ap-
proaches will improve outcomes for patients with severe and
treatment-refractory neuropsychiatric disorders.
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